DIET, LIFESTYLE AND CANCER IN U.S. SPECIAL POPULATIONS Release Date: February 23, 1998 PA NUMBER: PA-98-028 P.T. National Cancer Institute PURPOSE The Division of Cancer Control and Population Sciences of the National Cancer Institute (NCI) invites grant applications for epidemiologic studies to elucidate causes of cancer and means of prevention in African Americans, American Indians, Alaska Natives, Asian and Pacific Islanders, Native Hawaiians, Hispanics, rural, older, low income and low-literacy groups. These groups experience unusually high cancer incidence and mortality for some cancer sites. The reasons for the disparate rates may be differences in environmental exposures, socioeconomic factors, modifiable behavioral risk factors (such as diet, smoking, alcohol intake and physical activity), access and utilization of screening, treatment and rehabilitation services, and the presence of inherited susceptibilities. Furthermore, changing demographics in the U. S., revolutions in communications and informatics, and health care management coupled with explosive growth in molecular biology research open up vast new areas for research, the success of which will require multidisciplinary efforts. HEALTHY PEOPLE 2000 The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2000," a PHS-led national activity for setting priority areas. This Program Announcement (PA) is related to the priority area of cancer in minorities. and underserved populations. Potential applicants may obtain a copy of "Healthy People 2000" (Full Report: Stock No. 017-001-00474-0 or Summary Report: Stock No. 017-001- 00473-1) through the Superintendent of Documents, Government Printing Office, Washington, DC 20402-9325, telephone 202-512-1800. ELIGIBILITY REQUIREMENTS Applications may be submitted by domestic and foreign, for-profit and non- profit organizations, public and private, such as universities, colleges, hospitals, laboratories, units of State or local Government, and eligible agencies of the Federal Government, and small businesses. Foreign institutions are not eligible for program project (P01) grants. Racial/ethnic minority individuals, women and persons with disabilities are encouraged to apply as Principal Investigators. MECHANISM OF SUPPORT Support of this program will be through the National Institutes of Health (NIH) program project grant (P01) and traditional research project grant (R01). Applicants will be responsible for the planning, direction, and execution of the proposed project. Applicants requesting budgets greater than $500,000 in direct costs are required to contact program staff in the appropriate NIH institute prior to submitting their applications (NIH GUIDE, Vol. 25, No. 14, May 3, 1996). Applicants with budget of more than $500,000 in direct costs that are submitted without prior communication with NIH program staff will not be accepted for review. Prospective applicants are encouraged to discuss their ideas with NCI program staff listed under INQUIRIES. RESEARCH OBJECTIVES Background Cancer incidence varies widely among racial and ethnic groups around the world. The diversity of the US population offers unique opportunities for epidemiologic studies of cancer etiology in various ethnic/minority and underserved populations. A recently prepared monograph on "Racial/Ethnic Patterns of Cancer in the United States 1988-1992" published by the Surveillance, Epidemiology and End Results Program of the National Cancer Institute reveals strikingly varying cancer rates across population subgroups (1). Overall, age-adjusted cancer incidence rates are higher in men, ranging from 196 for American Indians (New Mexico) to 560 for African Americans per 100,000 population. In women, cancer incidence rates range from 180 for American Indians (New Mexico) and Koreans to 354 for White Non-Hispanic women per 100,000 population (Table 1). Epidemiologic studies of secular trends in cancer incidence and of cancer patterns among migrants suggest environmental factors as the major determinants of cancer risk. Higgins and Muir (2) attributed over 85% of the cancer burden to exogenous exposures. However, to date, only cigarette smoking has been established clearly as a major risk factor for cancer. Several other causes of cancer are known, including ultraviolet and ionizing radiation, certain drugs, infectious agents such as hepatitis B virus and human papillomavirus, and exposure to certain chemicals in the occupational environment (3). The contributions of these non-smoking exposures to the total cancer burden in the U S. appear to be relatively small. Doll and Peto (4) estimated that dietary factors are responsible for about one-third of all cancers in the U.S. Epidemiologic studies have provided clues about the influence of environmental exposures and cultural/lifestyle factors in cancer causation. However, the specific role of dietary practices and nutritional status in host susceptibility needs to be clarified. Diet may influence cancer risk in a number of ways: through exposure to carcinogens as food contaminants; through the formation of carcinogens during the storage, processing or cooking of foods; through carcinogens produced in vivo from ingested food; through the protective effect of certain dietary components and through effects from under nutrition on the immune system. It is unknown whether dietary interactions with other exposures, such as cigarette smoke or occupational substances, influence cancer development. Research Scope and Goals The purpose of this program announcement is to stimulate epidemiologic studies of cancer etiology and behavior in special populations of the US. Innovative approaches that involve inter-disciplinary collaborations of basic, behavioral or clinical researchers with epidemiologists are encouraged. Whenever possible, studies should make cost-efficient use of existing resources, such as population-based cancer registries or specimen repositories. The initiative permits a wide range of epidemiologic investigations of cancer in US special populations. The areas of research listed below are not intended to be all-inclusive, but are designed to give the applicant some direction for the types of research that the NCI is interested in stimulating to enhance knowledge about the etiology of various cancers and means for their prevention. 1. Cross-cultural studies of cancers with striking ethnic disparities in incidence rates, among groups residing in the same or different geographic areas, to identify more specifically the etiologic factors and to study their relationships with biomarkers of exposure. 2. Analytic studies of specific cancer sites to determine the impact of age- specific changes in exposure over time, due to waves of migration within the US as well as from other countries, and/or secular changes in lifestyle, occupation and environment. 3. Studies of ethnic differences in the histologic and cytologic parameters of particular cancers that may reflect differences in exposures or susceptibility. 4. Studies addressing methodological issues related to the heterogeneity of ethnic groups, especially dietary and genetic parameters. 5. Molecular epidemiologic studies exploring differences in genetic predisposition to cancer due to variations in carcinogen metabolism, DNA repair activities, response to tumor promoters, measures of immune function, chromosome sensitivity to mutagens, or other factors. 6. Development and validation of instruments for assessing diet and lifestyle factors such as smoking, alcohol intake and exercise and their role in the risk of cancer among understudied special populations. 7. Studies among Hispanics with special consideration given to the assessment of Hispanic ethnicity within the study population. 8. Feasibility studies to establish cohorts of Native Americans for elucidating causes of illness and assessing influence of lifestyle changes on disease risk. 9. Studies exploring culturally sensitive and socioeconomically sensitive, appropriately tailored approaches for dietary modification, monitoring compliance via appropriate means, to assess cancer risk in U. S. special populations. 10. Studies of motivational and behavioral strategies, including use of adjuncts, on diet modification and other lifestyle changes. INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS It is the policy of the NIH that women and members of minority groups and their subpopulations must be included in all NIH supported biomedical and behavioral research projects involving human subjects, unless a clear and compelling rationale and justification is provided that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This policy results from the NIH Revitalization Act of 1993 (section 492B of Public Law 103-43). All investigators proposing research involving human subjects should read the "NIH GUIDELINES FOR Inclusion of Women and Minorities as Subjects in Clinical Research," which have been published in the Federal Register of March 28, 1994 (FR 59 14508-14513) and in the NIH Guide for Grants and Contracts, Volume 23, Number 11, March 18, 1994. APPLICATION PROCEDURES Applications are to be submitted on the research grant application form PHS 398 (rev. 5/95) and will be accepted on the standard deadlines as indicated in the application kit. Application kits are available at most institutional offices of sponsored research and may be obtained from the Division of Extramural Outreach and Information Resources, National Institutes of Health, 6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892-7910, telephone 301/710-0267, email: [email protected]. The title and number of the program announcement must be typed in line 2 of the face page of the application and the YES box must be marked. It is strongly recommended that P01 applicants follow the instructions contained in the Program Project Guidelines of the National Cancer Institute booklet. Copies of the Guidelines are available from the NCI Referral Officer at the address listed below. The completed original application and five legible copies of the R01 application or three legible copies of the P01 application must be sent or delivered to: CENTER FOR SCIENTIFIC REVIEW NATIONAL INSTITUTES OF HEALTH 6701 ROCKLEDGE DRIVE, ROOM 1040, MSC 7710 BETHESDA, MD 20892-7710 BETHESDA, MD 20817 (for express/courier service) Send two additional exact photocopies of the program project (P01) application to: Referral Officer Division of Extramural Activities National Cancer Institute 6130 Executive Boulevard, Room 636, MSC-7407 Bethesda, MD 20892-7407 Telephone: (301) 496-3428 FAX: (301) 402-0275 Email: [email protected] REVIEW CONSIDERATIONS Traditional research project grant (R01) applications will be assigned on the basis of established Public Health Services referral guidelines. Applications that are complete will be evaluated for scientific and technical merit by an appropriate peer review group convened in accordance with the standard NIH peer review procedures. As part of the initial merit review, all applications will receive a written critique and undergo a process in which only those applications deemed to have the highest scientific merit, generally the top half of applications under review, will be discussed, assigned a priority score, and receive a second level review by the appropriate national advisory board or council. Applications must be sufficiently complete so that they can be reviewed without a site visit. Review Criteria The goals of NIH-supported research are to advance our understanding of biological systems, improve the control of disease, and enhance health. The reviewers will discuss the following aspects of the application to assess the likelihood that the proposed research will have a substantial impact on the pursuit of these goals. Each of these criteria will be addressed and considered in assigning the overall score, weighting them as appropriate for each application. The application does not need to be strong in all categories to be judged likely to have a major scientific impact. For instance, the proposed research may not be innovative but is essential to move a field forward. The review criteria are: 1. Significance: Does this study address an important problem? If the aims of the application are achieved, how will scientific knowledge be advanced? What will be the effect of these studies on the concepts or methods that drive this field? 2. Approach: Are the conceptual framework, design, methods, and analyses adequately developed, well-integrated, and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alternative strategies? 3. Innovation: Does the project employ novel concepts, approaches or methods? Are the aims original and innovative? Does the project challenge existing paradigms or develop new methodologies or technologies? 4. Investigator: Is the investigator appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers (if any)? 5. Environment: Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed experiments take advantage of unique features of the scientific environment or employ useful collaborative arrangements? Is there evidence of institutional support? In addition to the above criteria, in accordance with NIH policy, all applications will also be reviewed with respect to the following: 6. Adequacy of plans to include both genders, and minorities and their subgroups as appropriate for the scientific goals of the research. Plans for the recruitment and retention of subjects will also be evaluated. 7. The adequacy of the proposed provisions for the protection of human subjects and animal welfare and the safety of the research environment. 8. The reasonableness of the proposed budget and duration in relation to the proposed research. Additional Review Criteria for P01 Applications: The R01 review criteria listed above apply to P01 applications. In addition, potential applicants should contact the NCI Referral Officer listed under APPLICATION PROCEDURES for detailed information on P01 review guidelines. AWARD CRITERIA Applications will compete for available funds. The following will be considered in making funding decisions: quality of the proposed project as determined by peer review, availability of funds, and program balance and priority. INQUIRIES Inquiries are encouraged, particularly during the planning phase of the grant applications. The opportunity to clarify any issues or questions from potential applicants is welcome. Direct inquiries regarding programmatic issues to: Dr. A.R. Patel Division of Cancer Control and Population Sciences National Cancer Institute 6130 Executive Boulevard, Suite 535, MSC 7395 Bethesda, MD 20892-7395 Telephone: (301) 496-9600 FAX: (301) 402-4279 Email: [email protected] Direct inquiries regarding fiscal matters to: Mr. Bill Wells Grants Administration Branch National Cancer Institute 6120 Executive Boulevard, Suite 243, MSC 7150 Bethesda, MD 20892-7150 Telephone: (301) 496-7800, ext 250 FAX: (301) 496-8601 Email: [email protected] AUTHORITY AND REGULATIONS This program is described in the Catalog of Federal Domestic Assistance No. 93.393. Awards are made under authorization of the Public Health Service Act, Title IV, Part A (Public Law 78-140, as amended by Public Law 99.158, 42 U.S.C. 241 and 285) and administered under HHS policies and grant regulations. This program is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. The PHS strongly encourages all grant recipients to provide a smoke-free workplace and promote the non-use of all tobacco products. In addition, Public Law 103-227, The Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people. References 1. Racial/ethnic patterns of cancer in the United States 1988-1992. NIH Publication 96-4104, April 1996. 2. Higginson, J. and Muir, C.S., Environmental carcinogenesis: misconceptions and limitations to cancer control. J. Natl. Cancer Inst., 63, 1291-1298, 1979. 3. Schottenfeld, D. and Fraumeni, J.F., Jr., Cancer epidemiology and prevention 2nd edition, 1996 Oxford University Press, New York, 1996. 4. Doll, R. and Peto, R., The causes of cancer: quantitative estimates of available risks of cancer in the United States today. J. Natl. Cancer Inst., 66, 1191-1308, 1981. Table 1 ALL CANCERS COMBINED: SEER INCIDENCE RATES 1988-1992 Men Rate Women Rate African American 560 White, Non-Hispanic 354 White, Non-Hispanic 481 Alaska Native 348 Alaska Native 372 African American 326 Hawaiian 340 Hawaiian 321 White Hispanic 336 Vietnamese 273 Vietnamese 326 White Hispanic 256 Japanese 322 Hispanic (total) 243 Hispanic (total) 319 Japanese 241 Chinese 282 Filipino 224 Filipino 274 Chinese 213 Korean 266 Korean 180 Amer. Indian (NM) 196 Amer. Indian (NM) 180 Note: rates are average annual per 100,000 population, age-adjusted to 1970 US standard
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||